Luteolin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells

Oncogene
Ranxin ShiHan-Ming Shen

Abstract

Tumor necrosis factor-alpha (TNFalpha) activates both cell death and cell survival pathways, which render most cancer cells resistant to its cytotoxicity. In this study, we found that pretreatment with luteolin, a plant flavonoid, greatly sensitized TNFalpha-induced apoptotic cell death in a number of human cancer cell lines; including colorectal cancer COLO205, HCT116 cells and cervical cancer HeLa cells. In the search of the molecular mechanisms responsible for the sensitization effect of luteolin, we discovered that luteolin inhibited TNFalpha-induced activation of nuclear transcription factor-kappa B (NF-kappaB), the main survival factor in TNFalpha signaling. As a result, luteolin suppressed the expression of NF-kappaB-targeted antiapoptotic genes, including A20 and cellular inhibitor of apoptosis protein-1 (c-IAP1). The role of A20 and c-IAP1 was further confirmed by ectopic expression of these two genes, which significantly protected cell death induced by luteolin followed by TNFalpha. In addition, inhibition of NF-kappaB by luteolin led to augmentation and prolongation of c-Jun N-terminal kinase (JNK) activation induced by TNFalpha. Suppression of JNK activation, either by a synthetic JNK inhibitor (SP600125) or by over...Continue Reading

References

Jan 1, 1993·Annual Review of Cell Biology·K J Tracey, A Cerami
Jun 25, 1996·Proceedings of the National Academy of Sciences of the United States of America·H Y SongD V Goeddel
Jan 31, 1997·The Journal of Biological Chemistry·M MuzioV M Dixit
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·M E GerritsenT Collins
May 13, 1998·European Journal of Endocrinology·O MurakamiT Mouri
Jul 10, 1999·The International Journal of Biochemistry & Cell Biology·A Strasser, K Newton
Jul 27, 1999·The British Journal of Surgery·Y SakamotoM Makuuchi
Mar 14, 2000·Molecular and Cellular Biology·S P HehnerM L Schmitz
Jun 3, 2000·Annual Review of Immunology·M Karin, Y Ben-Neriah
Aug 10, 2000·Archives of Biochemistry and Biophysics·C F YangC N Ong
Feb 13, 2001·The Journal of Clinical Investigation·Y Yamamoto, R B Gaynor
Feb 13, 2001·The Journal of Clinical Investigation·A S Baldwin
Mar 10, 2001·Cold Spring Harbor Symposia on Quantitative Biology·M Delhase, M Karin
May 26, 2001·Annual Review of Nutrition·C S YangH L Newmark
Jun 1, 2001·Emerging Infectious Diseases·Y J HutinJ J Esposito
Jul 21, 2001·Molecular and Cellular Biology·O MicheauJ Tschopp
Aug 30, 2001·Cell Death and Differentiation·G DeneckerP Vandenabeele
Oct 2, 2001·Pharmacology & Therapeutics·D F BirtW Wang
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·B L BennettD W Anderson
Feb 28, 2002·Reproduction : the Official Journal of the Society for the Study of Fertility·Z M ZhouK Y Zhou
Mar 5, 2002·Nature Immunology·Michael Karin, Anning Lin
Mar 22, 2002·Nature·Xiaoming LiJonathan D Ashwell
Apr 18, 2002·Oncogene·Sung Su KimYoo-Hun Suh
Jun 1, 2002·Science·Guoqing Chen, David V Goeddel
Jun 11, 2002·Annual Review of Nutrition·Julie A Ross, Christine M Kasum

❮ Previous
Next ❯

Citations

Feb 13, 2009·Apoptosis : an International Journal on Programmed Cell Death·Han-Ming Shen, Vinay Tergaonkar
Jan 14, 2009·Investigational New Drugs·Kathy Ka-Wai Auyeung, Joshua Ka-Shun Ko
Jun 11, 2008·Neuromolecular Medicine·Tae Gen SonMark P Mattson
Jul 31, 2012·Journal of Agricultural and Food Chemistry·Dan-feng LuGuo-lin Zhang
Nov 3, 2012·Journal of Agricultural and Food Chemistry·Noor Idayu TahirUmi Salamah Ramli
Sep 8, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Kyung Pyo KangWon Kim
Jan 1, 2008·International Journal of Molecular Sciences·Ewelina SzliszkaWojciech Król
Mar 19, 2014·Chinese Journal of Natural Medicines·Mei-Wan ChenYi-Tao Wang
Nov 7, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Jia-Ping LaiChoon Nam Ong
Mar 15, 2016·Biomedit︠s︡inskai︠a︡ khimii︠a︡·A M PopovA A Artyukov
Apr 30, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Vazhapilly Cijo GeorgeRangasamy Ashok Kumar
Jan 16, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Ting-Ting WangGui-Ju Sun
May 24, 2011·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Xueting CaiPeng Cao
Jan 23, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Anna Palko-LabuzKrystyna Michalak
Apr 11, 2017·Cancer Chemotherapy and Pharmacology·Qiang WangHui Ding
Jan 29, 2013·Experimental Biology and Medicine·Sreemanti DasAnisur Rahman Khuda-Bukhsh
Aug 12, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Do Y LimJung H Y Park
Jun 2, 2017·Experimental and Therapeutic Medicine·Olga Nikolaevna StyshovaAnna Anatolievna Klimovich
Apr 19, 2019·Antioxidants·Meenakshi SudhakaranAndrea I Doseff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.